XML 42 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings (Deficit) [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Cumulative effect of accounting change of the Joint Venture | ASU 2017-12 [Member]     $ (490) $ 490  
Balance at Mar. 31, 2018 $ 75 $ 1,139,300 34,661 2,536 $ 1,176,572
Balance, shares at Mar. 31, 2018 75,749,118        
Equity compensation expense   5,300     5,300
Repurchase of Change Healthcare Inc. common stock   (4,782)     (4,782)
Repurchase of Change Healthcare Inc. common stock, shares (251,789)        
Issuance of Change Healthcare Inc. common stock upon exercise of equity awards, shares 4,045        
Net income (loss)     (17,501)   (17,501)
Foreign currency translation adjustment of the Joint Venture       (2,593) (2,593)
Changes in fair value of interest rate swap, net of taxes       782 782
Balance at Jun. 30, 2018 $ 75 1,139,818 16,670 1,215 1,157,778
Balance, shares at Jun. 30, 2018 75,501,374        
Balance at Mar. 31, 2018 $ 75 1,139,300 34,661 2,536 1,176,572
Balance, shares at Mar. 31, 2018 75,749,118        
Net income (loss)         (36,092)
Foreign currency translation adjustment of the Joint Venture         (2,027)
Changes in fair value of interest rate swap, net of taxes         2,260
Balance at Sep. 30, 2018 $ 75 1,141,067 (1,921) 3,259 1,142,480
Balance, shares at Sep. 30, 2018 75,445,885        
Balance at Jun. 30, 2018 $ 75 1,139,818 16,670 1,215 1,157,778
Balance, shares at Jun. 30, 2018 75,501,374        
Equity compensation expense   2,969     2,969
Repurchase of Change Healthcare Inc. common stock   (1,720)     (1,720)
Repurchase of Change Healthcare Inc. common stock, shares (90,629)        
Issuance of Change Healthcare Inc. common stock upon exercise of equity awards, shares 35,139        
Net income (loss)     (18,591)   (18,591)
Foreign currency translation adjustment of the Joint Venture       566 566
Changes in fair value of interest rate swap, net of taxes       1,478 1,478
Balance at Sep. 30, 2018 $ 75 1,141,067 (1,921) 3,259 1,142,480
Balance, shares at Sep. 30, 2018 75,445,885        
Cumulative effect of accounting change of the Joint Venture | ASC 606 [Member]     35,797   35,797
Cumulative effect of accounting change of the Joint Venture | ASU 2018-02 [Member]     (422) 422  
Balance at Mar. 31, 2019 $ 75 1,153,509 (17,841) (3,256) 1,132,487
Balance, shares at Mar. 31, 2019 75,474,654        
Equity compensation expense   5,862     5,862
Net income (loss)     (37,517)   (37,517)
Foreign currency translation adjustment of the Joint Venture       226 226
Changes in fair value of interest rate swap, net of taxes       (5,431) (5,431)
Balance at Jun. 30, 2019 $ 75 1,159,371 (19,983) (8,039) 1,131,424
Balance, shares at Jun. 30, 2019 75,474,654        
Balance at Mar. 31, 2019 $ 75 1,153,509 (17,841) (3,256) 1,132,487
Balance, shares at Mar. 31, 2019 75,474,654        
Net income (loss)         (131,451)
Unrealized gain (loss) on available for sale debt securities of the Joint Venture         1,173
Foreign currency translation adjustment of the Joint Venture         1,809
Changes in fair value of interest rate swap, net of taxes         (6,741)
Balance at Sep. 30, 2019 $ 124 2,006,494 (113,918) (6,593) 1,886,107
Balance, shares at Sep. 30, 2019 124,935,806        
Balance at Jun. 30, 2019 $ 75 1,159,371 (19,983) (8,039) 1,131,424
Balance, shares at Jun. 30, 2019 75,474,654        
Issuance of Change Healthcare Inc. common stock upon initial public offering $ 49 608,630     608,679
Issuance of Change Healthcare Inc. common stock upon initial public offering, shares 49,285,713        
Effect of initial public offering issuance costs on Joint Venture equity   (4,160)     (4,160)
Issuance of tangible equity units   232,929     232,929
Equity compensation expense   8,585     8,585
Issuance of Change Healthcare Inc. common stock upon exercise of equity awards   1,139     1,139
Issuance of Change Healthcare Inc. common stock upon exercise of equity awards, shares 175,439        
Net income (loss)     (93,935)   (93,935)
Unrealized gain (loss) on available for sale debt securities of the Joint Venture       1,173 1,173
Foreign currency translation adjustment of the Joint Venture       1,583 1,583
Changes in fair value of interest rate swap, net of taxes       (1,310) (1,310)
Balance at Sep. 30, 2019 $ 124 $ 2,006,494 $ (113,918) $ (6,593) $ 1,886,107
Balance, shares at Sep. 30, 2019 124,935,806